Management of malignant glioma: role of surgery in relation to multimodality therapy

Reference

• Ammirati M., Vick N., Liao Y. L., Ciric I., Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 1987; 21: 201–206
   PubMed Web of Science ®Google Scholar
• Beaney R. P., Brooks D. J., Leenders K. L., Thomas D. G., Jones T., Hainan KE. Blood flow and oxygen utilisation in the contralateral cerebral cortex of patients with untreated intracranial tumours as studied by positron emission tomography, with observations on the effect of decompressive surgery. J Neurol Neurosurg Psychiatr 1985; 48: 310–319
   Google Scholar
• Brem H. Personal Communication. Brem H., Piantadosi S., Burger P. C., Walker M., Selker R., Vick N. A., Black K., Sisti M., Brem S., Mohr G., Muller P., Morawetz R., Schold S. C., and The Polymer-Brain Tumor Study Group (1995). Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1997; 345: 1008–1012
   Google Scholar
• Burger PC. The anatomy of astrocytomas. Mayo Clin Proc 1987; 62: 527–529
   Google Scholar
• Chang C. H., Horton J., Schoenfeld D., Salazer O., Perez-Tamayo R., Kramer S., Weinstein A., Nelson J. S., Tsukada Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 1983; 52: 999–1007
   Google Scholar
• Choksey M. S., Valentine A., Shawdon H., Freer C. E., Lindsay KW. Computed tomography in the diagnosis of malignant brain tumours: do all patients require biopsy?. J Neurol Neurosurg & Psychiatr 1989; 52: 821–825
   PubMedGoogle Scholar
• Ciric I., Ammirati M., Vick N., Mikhael M. Supratentorial gliomas: Surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery 1987; 21: 21–26
   PubMed Web of Science ®Google Scholar
• Coffey R. J., Lunsford L. D., Taylor FH. Survival after stereotactic biopsy of malignant gliomas. Neurosurgery 1988; 22: 465–473
   PubMed Web of Science ®Google Scholar
• Darling J. L., Lewandowicz G. M., Thomas DGT. Chemosensitivity testing of human malignant brain tumors. Advances in Neuro-Oncology II, PL Kornblith, MD Walker. Futura Publishing Co. Armonk, New York 1997; 413–434
   Google Scholar
• Dyck P., Bouzaglou A., Solti-Bohman L. G., Gruskin P. Computer-aided, CT-guided biopsy and brachytherapy of brain tumors. Bull Clin Neurosci 1983; 48: 122–138
   Google Scholar
• Fadul C., Wood J., Thaler H., Galicich J., Patterson R. H., Jr, Posner JB. Morbidity and mortality of craniot-omy for excision of supratentorial gliomas. Neurology 1988; 38: 1374–1379
   PubMed Web of Science ®Google Scholar
• Forsting M., Albert F. K., Kunze S., Adams H. P., Zenner D., Sartor K. Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns. AJNR 1993; 14: 77–87
   PubMed Web of Science ®Google Scholar
• Fransen P., De Tribolet N. Surgery of supratentorial tumors. Current Opinion in Oncology 1993; 5: 450–457
   Google Scholar
• Green S. B., Byar D. P., Walker M. D., Pistenmaa D. A., Alexander E., Jr, Batzdorf U., Brooks W. H., Hunt W. E., Mealey J., Jr, Odom G. L., Paoletti P., Ransohoff J., 2nd, Robertson J. T., Selker R. G., Shapiro W. R., Smith K. R., Jr, Wilson C. B., Strike TA. Comparisons of carmus-tine, procarbazine and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983; 67: 121–132
   PubMedGoogle Scholar
• Gutin P. H., Leibel SA. Stereotaxic interstitial irradiation of malignant brain tumors. Neurol Clin 1985; 3: 883–893
   Google Scholar
• Halperin E. C., Burger P. C., Bullard DE. The fallacy of the localized supratentorial malignant glioma. Int J Radiation Oncol Biol Phys 1988; 15: 505–509
   PubMed Web of Science ®Google Scholar
• Harsh GR I. V., Levin V. A., Gutin P. H., Seager M., Silver P., Wilson CB. Reoperation for recurrent glioblas-toma and anaplastic astrocytoma. Neurosurgery 1987; 21: 615–621
   PubMed Web of Science ®Google Scholar
• Hochberg F. H., Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980; 30: 907–911
   PubMed Web of Science ®Google Scholar
• Hollerhage H. G., Zumkeller M., Becker M., Dietz H. Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme. Acta Neurochir (Wien) 1991; 113: 31–37
   Google Scholar
• Hoshino T. A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. J Neurosurg 1984; 61: 895–900
   PubMed Web of Science ®Google Scholar
• Jelsma R., Bucy PC. The treatment of glioblastoma multiforme of the brain. J Neurosurg 1967; 27: 388–400
   PubMed Web of Science ®Google Scholar
• Jeremic B., Grujicic D., Antunovic V., Djuric L., Stojanovic M., Shibamoto Y. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neuro-Oncol 1994; 21: 177–185
   PubMed Web of Science ®Google Scholar
• Kala M., Sramek V., Houdek M., Vaverka M., Zmrzlik P. Treatment of glioblastoma multiforme (Czech). Casopis Lekaru Ceskych 1993; 132: 653–656
   Google Scholar
• Kelly P. J., Daumas-Duport C., Scheithauer B. W., Kall B. A., Kispert DB. Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987; 62: 450–459
   PubMed Web of Science ®Google Scholar
• Kreth F. W., Warnke P. C., Scheremet R., Ostertag CB. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 1993; 78: 762–766
   PubMed Web of Science ®Google Scholar
• Kristiansen K., Hagen S., Kollevold T., Torvik A., Holme I., Nesbakken R., Hatlevoll R., Lindgren M., Brun A., Lindgren S., Notter G., Andersen A. P., Elgen K. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981; 47: 649–652
   PubMed Web of Science ®Google Scholar
• Larner J. M., Phillips C. D., Dion J. E., Jensen M. E., Newman S. A., Jane JA. A phase 1–2 trial of superselective carboplatin, low-dose infusional 5-fluorouracil and concurrent radiation for high-grade gliomas. Am J Clin Oncol 1995; 18: 1–7
   PubMed Web of Science ®Google Scholar
• Laws ER, Jr. Radical resection for the treatment of glioma. Clin Neurosurg 1995; 42: 480–487
   Google Scholar
• Marshall L. F., Jennett B., Langfitt TW. Needle biopsy for the diagnosis of malignant glioma. JAMA 1974; 228: 1417–1418
   PubMed Web of Science ®Google Scholar
• Miyamoto C. T., Brady L. W., Rackover M. A., Emrich J., Class R., Bender H., Micaily B., Steplewski Z. The use of epidermal growth factor receptor-425 monoclonal antibodies radiolabeled with Iodine-125 in the adjuvant treatment of patients with high grade gliomas of the brain. Systemic Radiotherapy with Monoclonal Antibodies. Options and Problems, M-L Sautter-Bihl, H. Bihl, M Wannenmacher. Springer-Verlag, Berlin, Heidelberg 1996; 183–192
   Google Scholar
• MÜLler W., ÁFra D., SchrÖDer R. Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas. Acta Neurochir 1977; 37: 75–91, (Wien)
   PubMed Web of Science ®Google Scholar
• Nazzaro J. M., Neuwelt EA. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 1990; 73: 331–344
   PubMed Web of Science ®Google Scholar
• Nitta T., Sato K. Prognostic implications of the extent of surgical resection in patients with intracra-nial malignant gliomas. Cancer 1995; 75: 2727–2731
   PubMedGoogle Scholar
• Rajan B., Pickuth D., Ashley S., Traish D., Monro P., Elyan S., Brada M. The management of histologically unverified presumed cerebral gliomas with radiotherapy. Int J Radiation Oncol Biol Phys 1994; 28: 405–413
   PubMedGoogle Scholar
• Ram Z., Oldfield EH. Genetic approaches for the therapy of malignant brain tumors. Advances in Neuro-Oncology II, P. L. Kornblith, MD Walker. Futura Publishing Co, Armonk, New York 1997; 541–551
   Google Scholar
• Rostomily R. C., Spence A. M., Duong D., Mccormick K., Bland M., Berger MS. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery 1994; 35: 378–388
   PubMed Web of Science ®Google Scholar
• Salcman M., Kaplan R. S., Samaras G. M., Ducker T. B., Broadwell D. Aggressive multimodality therapy based on a multicompartmental model of glioblastoma. Surgery 1982; 92: 250–259
   Google Scholar
• Salcman M. Supratentorial gliomas: Clinical features and surgical therapy. Neurosurgery, R. J. Wilkins, SS Rengarchary. McGraw-Hill Book Co., New York 1985; vol 1: 579–590
   Google Scholar
• Salcman M. Malignant glioma management. Neurosurg Clin N Amer 1990; 1: 49–63
   PubMedGoogle Scholar
• Salcman M. Supratentorial gliomas: Clinical features and surgical therapy. Neurosurgery Second, RJ Wilkins, SS Rengachary. McGraw-Hill Book Co., New York 1996; vol 1: 777–788
   Google Scholar
• Sandeman D. R., Sandeman A. P., Buxton P., Hughes H. H., Chadwick D. W., Williams I. R., Baker R. D., Foy P. M., Shaw DM. The management of patients with an intrinsic supratentorial brain tumour. Br J Neurosurg 1990; 4: 299–312
   PubMedGoogle Scholar
• Shapiro WR. Treatment of neuroectodermal brain tumors. Ann Neurol 1982; 12: 231–237
   PubMed Web of Science ®Google Scholar
• Simpson J. R., Horton J., Scott C., Curran W. J., Rubin P., Fischbach J., Isaacson S., Rotman M., Asbell S. O., Nelson J. S., Weinstein A. S., Nelson DF. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiation Oncology Biol Phys 1993; 26: 239–244
   PubMed Web of Science ®Google Scholar
• Tada M., De Tribolet N. Immunobiology of malignant gliomas. Advances in Neuro-Oncology II, L. Kornblith P, MD Walker. Futura Publishing Co., Armonk, New York 1997; 447–467
   Google Scholar
• Valtonen S., Timonen U., Toivanen P., Kalimo H., Kivipelto L., Heiskanen O., Unsgaard G., Kuurne T. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 1997; 41: 44–48
   PubMed Web of Science ®Google Scholar
• Vecht C. J., Avezaat C. J., Van Putten W. L., Eijkenboom W. M., Stefanko SZ. The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatr 1990; 53: 466–471
   PubMed Web of Science ®Google Scholar
• Walker M. D., Alexander E., Jr, Hunt W. E., Maccarty C. S., Mahaley M. S., Jr, Mealey J., Jr, Norrell H. A., Owens G., Ransohoff J., Wilson C. B., Gehan E. A., Strike TA. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978; 49: 333–343
   PubMed Web of Science ®Google Scholar
• Walker M. D., Green S. B., Byar D. P., Alexander E., Jr, Batzdorf U., Brooks W. H., Hunt W. E., Maccarty C. S., Mahaley M. S., Jr, Mealey J., Jr, Owens G., Ransohoff J, 2nd, Robertson J. T., Shapiro W. R., Smith K. R., Jr, Wilson C. B., Strike TA. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. New Engl J Med 1980; 303: 1323–1329
   PubMed Web of Science ®Google Scholar
• Young B., Oldfield E. H., Markesbery W. R., Haack D., Tibbs P. A., Mccombs P., Chin H. W., Maruyama Y., Meacham WF. Reoperation for glioblastoma. J Neurosurg 1981; 55: 917–921
   PubMed Web of Science ®Google Scholar